LexaGene in Cleanroom Technology
LexaGene’s beta installation at CDX cannabis testing facilities featured in Cleanroom Technology. The article describes how LexaGene is bringing better detection to the cannabis testing market.
Boston Business Journal article
Boston Business Journal featured LexaGene in a story about how the company is trying to tackle possible under-reporting of EEE virus.
LexaGene featured on CBS Boston 4
LexaGene was featured on CBS Boston 4 WBZ during the news reporting of the EEE virus outbreak in Massachusetts
and other states.
Feature on Investing News Network
Read Investing News Network’s story on LexaGene – LexaGene Tackling Antibiotic Resistance with Genetic Analyzer.
Interview on EEE Testing
LexaGene CEO Dr. Jack Regan speaks to Proactive Investors explaining what LexaGene is doing to help respond to the rising threat of EEE Virus in Massachusetts and other states. Watch video.
LexaGene interview on CDX beta results
LexaGene CEO Dr. Jack Regan discusses the beta testing LexaGene completed with CDX Analytics for rapid pathogen detection in cannabis and hemp. Watch video.
LexaGene discusses ASL beta testing for Human Clinical
LexaGene CEO Dr. Jack Regan discusses beta testing client Assurance Scientific Laboratories (ASL) and their plans to use the LX Analyzer prototype in human clinical diagnostics. Watch video.
BioSpace article on LexaGene antibiotic resistance testing
Read BioSpace article on LexaGene’s news: The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.
LexaGene discusses FDA AR Isolate Bank
LexaGene discusses recent approval by CDC and FDA Antibiotic Resistance Isolate Bank to receive samples for testing. Watch video.
Interview on filing three additional patents
LexaGene CEO Dr. Jack Regan discusses the recent filing of three additional patents and plans for the company. Watch video.
Interview on Antibiotic Resistance Panel
Dr. Jack Regan discusses LexaGene’s development of an antibiotic resistance panel to detect antibiotic resistance in pathogens in just one hour.
LexaGene featured on Uptick Newswire
LexaGene President Daryl Rebeck joins Uptick News to discuss developing a commercialized and easy to use genetic analyzer for use in multiple markets.